Moonsigns  |  Band Guide  |  Blogs  |  In Pictures  |  Adult
Boston  |  Portland  |  Providence  |  Stuff at Night
 
Letters  |  Media -- Dont Quote Me  |  News Features  |  Talking Politics  |  The Editorial Page

Leery of Leary
In 1959, Leary had just begun a lecturer position in psychology at Harvard. After an acquaintance told him about the religious history of psychedelic mushrooms, Leary decided to try it for himself. He wrote later that it completely transformed his understanding of consciousness, and sent him on a path from which, except for a few stints in prison, he would never stray. Along with his colleague at Harvard, and fellow psychology professor Alpert (today known as Baba Ram Dass), Leary was able to begin a legitimate study of psilocybin and other drugs, sanctioned by the university with the promise by Leary and Alpert that they would keep it aboveboard.

Eventually it was discovered by university officials that Leary and Alpert were indeed giving LSD and psilocybin to undergraduates, as well as to other professors. By then the rumor mill was at full tilt; 1963 saw an explosion of talk on campus about all-night drug parties at Leary’s house.

A few days before Leary and Alpert were officially expelled in May of 1963, the New York Times reported that the decision to oust the duo had already come down from the college president, Nathan Pusey. The paper described a growing fear among officials at Harvard and other colleges of students holding “private psilocybin parties.”

Leary and Alpert acquired a huge and shambling mansion in Milbrook, New York, where they continued their experiments. They were regularly visited by artists, musicians, and freaks of every kind. LSD became illegal in 1966 (psilocybin in 1971) and many of the original researchers, including Hofmann, were unhappy with where Leary had taken the public’s understanding of the drug. Leary, they complained, took them out of the purview of science and put them into the hands of, well, dirty hippies everywhere.

But the criminalization of such hallucinogens as LSD and mushrooms didn’t just affect the Haight-Ashbury crowd. Eventually, authorities targeted other hallucinogens and made them illegal as well. Mescaline, the psychedelic compound found in the peyote cactus, was also listed as a Schedule 1 drug (meaning it was understood to have no accepted medical use, a high potential for dependence or harm, and no parameters for safe administration). Nevertheless, Native Americans had long used this plant as an important part of their religious rituals. Halpern, who spent years working with Native Americans for his research, witnessed firsthand how dear peyote is to them and their culture. “This is their heart,” says Halpern. “The leaders say, ‘You have taken our land, tried to take our way of life, our language, now all we have left is this peyote.’ ” Eventually, in 1996, under very strict regulations, members of the Native American Church (NAC) were given permission to use peyote in their ceremonies, but this did little to change the national anxiety over psychedelic drugs.

Halpern’s research revealed that members of the NAC suffer no ill effects from the ingestion of peyote, and in fact have lower rates of alcoholism and drug addiction than the general population. I was curious whether Halpern participated in any of the ceremonies and, if so, if he had lost any objectivity as a scientist. “I had been invited by the leadership of NAC to ‘pray with them,’ which means to take peyote,” says Halpern. “I would not be able to do the work if I had not.” As a scientist, his job was to report harms if he found them. But he didn’t find any.

080530_lsd_main2
THE NEW GURUS: Rick Doblin (left) and Dr. John Halpern could bring psychedelics back to respectable research.

‘It’s about legitimate science’
When it comes to drug research, even professionals tend to be skeptical. Halpern says that some of his peers accused him of not doing legitimate work, but he defends it by noting that he wasn’t doing it alone in a bong-filled vacuum: “What about all my collaborators? What about the senior professors who are supervising my work, or the biostatisticians who evaluate the entire data set, or the research assistants independent of me, who are entering in the data? Are all those people biased too? It almost takes on a level of paranoia that something wrong is happening.”

So how did researching peyote lead Halpern to study MDMA and LSD, which have no accepted sacramental use? Halpern explains that the question of their status as psychedelic drugs with a controversial history is secondary to the possibility that they have real medical use, and immediately points to the example of Thalidomide, which caused terrible birth defects in children born in the late ’50s/early ’60s. Nevertheless, he notes, the drug did prove to have tremendous usefulness for alleviating pain in certain forms of cancer and very painful skin inflammation, and, under very controlled situations, is still prescribed.

“When Schedule 1 drugs are shown that they are effective, they become Schedule 2,” says Halpern. “And if they are abused, they can be prosecuted as Schedule 1. Some [similar] arrangement could be made for some of these [hallucinogenic] compounds, as well.”

< prev  1  |  2  |  3  |  4  |  5  |  6  |   next >
Related:
  • Changing concentrations
    As the world shrinks, schools expand their majors and programs
  • Making their mark
    The Phoenix gets out the red pen and grades 10 local campuses’ most daring experiments in modern architecture
  • Falwell U
    The Moral Majority's higher education
  • More more >
  Topics: News Features , Harvard University , Timothy Leary , Multidisciplinary Association for Psychedelic Studies ,  More more >
  • Share:
  • RSS feed Rss
  • Email this article to a friend Email
  • Print this article Print
Comments
Will Harvard drop acid again?
Nice article, with one exception: the author consistently misspells "Richard Alpert" as "Richard Albert".
By JDMF on 05/29/2008 at 10:56:44
Will Harvard drop acid again?
I am a Neuroscience major at Northeastern University and not once in the classroom have I heard a single mention of even a possible positive use from psychedelic drugs and marijuana, nor mention of the research done BEFORE Tim Leary. It is a shame that student's are only introduced to this area of medicine through opinionated articles like this rather than able to draw their own conclusions through scholarly study. (Though this article is better than most)
By HelptheSick on 05/29/2008 at 7:08:28
Will Harvard drop acid again?
Very well done article. Ironic that the anecdotal evidence that followed in the comments section, helped weed out a couple things that will not now need clinical trials. One thing that is evident after reading the comments from Voldemort, is that psychedelics are not a cure for professional jealousy nor that age old malady called cutting off one's nose to spite the face. What Voldemort does not seem to understand, remarkably after stating this was a well researched article, is that such articles have no place for innuendo, allegations from anonymous sources or rumour. Certainly those which have no direct relationship to the subject at hand. I believe Voldemort should reserve his/her character assassination for the upcoming Presidential elections where such tactics are standard fare for those that prefer personal gain over the good of the masses. With all due respect, it's possible Voldemort thought this article was a piece of science fiction and not a serious article, about serious research which can lead to helping millions of people that suffer from serious health issues such as OCD, PSTD and Cluster Headaches, to name a few. If this is the case, my sincere apologies.
By Eugene 'Saxe on 05/30/2008 at 2:41:24

election special
MOST POPULAR
RSS Feed of for the most popular articles
 Most Viewed   Most Emailed 
HOT TOPICS
 More Topics . . .



Featured Articles in Lifestyle Features:
Monday, November 10, 2008  |  Sign In  |  Register
 
thePhoenix.com:
Phoenix Media/Communications Group:
TODAY'S FEATURED ADVERTISERS
Copyright © 2008 The Phoenix Media/Communications Group